CN105770294A - Traditional Chinese medicine composition for treating hysteromyoma - Google Patents
Traditional Chinese medicine composition for treating hysteromyoma Download PDFInfo
- Publication number
- CN105770294A CN105770294A CN201610254199.XA CN201610254199A CN105770294A CN 105770294 A CN105770294 A CN 105770294A CN 201610254199 A CN201610254199 A CN 201610254199A CN 105770294 A CN105770294 A CN 105770294A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- radix
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
Abstract
The invention discloses a traditional Chinese medicine composition for treating hysteromyoma. The traditional Chinese medicine composition comprises the following traditional Chinese medicine raw materials in parts by weight: 10-30 parts of radix codonopsis, 10-20 parts of red paeony root, 5-15 parts of rhizoma cyperi, 10-20 parts of ground beetle, 10-20 parts of cleome, 10-20 parts of common selfheal fruit-spike, 5-15 parts of frankincense, 10-20 parts of concha arcae, 10-20 parts of cassia twig, 10-20 parts of poria cocos, 5-15 parts of sargassum, 10-20 parts of aralia elata, 10-20 parts of raspberry, 10-20 parts of angelica sinensis, 5-15 parts of euonymus alatus, 10-20 parts of concha meretricis seu cyclinae, 10-20 parts of fructus forsythiae, 5-15 parts of colla cornus cervi, 10-20 parts of tree peony bark, 10-20 parts of rose, 5-15 parts of gadfly tabanus, 10-20 parts of ludwigia octovalvis, 10-20 parts of dandelion and 10-20 parts of multiflora rose root. The traditional Chinese medicine composition disclosed by the invention has the effects of soothing liver and strengthening spleen, promoting blood circulation to remove blood stasis, promoting Qi circulation and relieving depression, and softening hardness to dissipate stagnation, and is obvious in curative effect on hysteromyoma and reliable in effect.
Description
Technical field
The present invention relates to the medicinal preparation not determining structure of a kind of traditional herbal medicines, a kind of Chinese medicine composition treating hysteromyoma.
Background technology
Hysteromyoma is modal a kind of benign tumor in female sex organ, is also one of modal tumor in human body, is also called fibromyoma, fibroma uteri.Most of patients is asymptomatic, is only occasionally found when pelvioscopy or ultrasonic examination.If any symptom then with muscular tumor growth site, speed, with or without degeneration and in close relations with or without complication, and relatively small with muscular tumor size, number how many relations.The most common symptom has: metrorrhagia, pain, leucorrhoea grow in quantity, infertile and miscarriage, abdominal mass and pressure symptom etc..At present, the most typically using hormone medicine treatment and surgical resection therapy, operative treatment organ damage whole to human body is relatively big, and costly;And hormone medicine long-term taking, it being easily generated dependency, side effect is big.
The traditional Chinese medical science is thought, hysteromyoma, mainly due to ferritic weakness, through row puerperal asthenia, experiences again cold-evil, cold-evil enters interior visitor in uterus, or stagnation of liver-QI void causes depression of liver-QI, spleen fortune is lost strong, no resource of generating and transforming QI and blood, finally cause qi stagnation blood stasis or blood stagnancy due to deficiency of QI, congestion condenses uterus, blocks vessels of the uterus, and punching is appointed impaired, fresh blood must not return through, with the passing of time formed.
According to theory of Chinese medical science, for the pathogeny of hysteromyoma, with soothing liver and strengthening spleen, blood circulation promoting and blood stasis dispelling as the rule for the treatment of, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome that the treatment hysteromyoma side effect of hormone medicine in prior art is big, deficiency that operative treatment hysteromyoma China wound is big, the present invention provide a kind of prepare conveniently, medicine source is wide, low cost, evident in efficacy, reliable effect, the Chinese medicine composition for the treatment of hysteromyoma having no side effect.
nullThe technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition treating hysteromyoma,It is characterized in that: its raw material of Chinese medicine and weight be: Radix Codonopsis 10-30 part,Radix Paeoniae Rubra 10-20 part,Rhizoma Cyperi 5-15 part,Eupolyphaga Seu Steleophaga 10-20 part,Herba Cleomis 10-20 part,Spica Prunellae 10-20 part,Olibanum 5-15 part,Concha Arcae 10-20 part,Ramulus Cinnamomi 10-20 part,Poria 10-20 part,Sargassum 5-15 part,Thorn fossilia dentis mastodi 10-20 part,Fructus Rubi 10-20 part,Radix Angelicae Sinensis 10-20 part,Ramulus Euonymi 5-15 part,Concha Meretricis seu Cyclinae 10-20 part,Fructus Forsythiae 10-20 part,Colla cornus cervi 5-15 part,Cortex Moutan 10-20 part,Flos Rosae Rugosae 10-20 part,Tabanus 5-15 part,Ludwigia octovalvis (Jacq.) Raven 10-20 part,Herba Taraxaci 10-20 part,Radix rosae multiflorae 10-20 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition treating hysteromyoma, it is characterized in that: its raw material of Chinese medicine and weight be: Radix Codonopsis 20 parts, Radix Paeoniae Rubra 15 parts, Rhizoma Cyperi 10 parts, Eupolyphaga Seu Steleophaga 15 parts, Herba Cleomis 15 parts, Spica Prunellae 15 parts, Olibanum 10 parts, Concha Arcae 15 parts, Ramulus Cinnamomi 15 parts, 15 parts of Poria, Sargassum 10 parts, thorn fossilia dentis mastodi 15 parts, Fructus Rubi 15 parts, Radix Angelicae Sinensis 15 parts, Ramulus Euonymi 10 parts, Concha Meretricis seu Cyclinae 15 parts, Fructus Forsythiae 15 parts, Colla cornus cervi 10 parts, Cortex Moutan 15 parts, Flos Rosae Rugosae 15 parts, Tabanus 10 parts, Ludwigia octovalvis (Jacq.) Raven 15 parts, Herba Taraxaci 15 parts, Radix rosae multiflorae 15 parts.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription.In Chinese medicine composition of the present invention: Radix Codonopsis has effect of invigorating the spleen and replenishing QI, strengthening spleen and tonifying lung;Radix Paeoniae Rubra has effect of clearing away heat and cooling blood, eliminating stasis to stop pain;Rhizoma Cyperi has effect of resolving depression of regulating the flow of vital energy, menstruction regulating and pain relieving;Eupolyphaga Seu Steleophaga has effect of eliminating stasis to stop pain, reunion of fractured tendons and bones;Herba Cleomis has effect of expelling wind and removing dampness, heat-clearing and toxic substances removing;Spica Prunellae has effect of liver heat removing and eyesight improving, clearing away heat and promoting diuresis, mass dissipating and swelling eliminating;Olibanum has effect of blood-activating and qi-promoting, pain relieving, detumescence and promoting granulation;Concha Arcae has effect of expectorant blood stasis dispelling, hard masses softening and resolving, relieving gastric hyperacidity to alleviate stomachache;Ramulus Cinnamomi has diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, effect of dispersing cold for relieving pain;Poria has promoting diuresis to eliminate damp pathogen, strengthening the spleen stomach function regulating, effect of mind tranquilizing and the heart calming;Sargassum has softening the hard mass expectorant, effect of diuretic detumescent;Thorn fossilia dentis mastodi has vital energy benefiting and the kidney invigorating, expelling wind and removing dampness, promoting blood circulation and stopping pain;Fructus Rubi has the liver and the kidney tonifying, controlling nocturnal emission with astringent drugs reducing urination, effect of supporing yang improving eyesight;Radix Angelicae Sinensis has replenishing and activating blood, menstruction regulating and pain relieving, effect of loosening bowel to relieve constipation;Ramulus Euonymi have removing blood stasis stimulate the menstrual flow, effect of removing toxic substances and promoting subsidence of swelling, parasite killing;Concha Meretricis seu Cyclinae has effect of clearing away heat and promoting diuresis, resolving phlegm and softening hard masses;Fructus Forsythiae has effect of heat-clearing and toxic substances removing, mass dissipating and swelling eliminating;Colla cornus cervi has temperature compensation Liver and kidney, effect of benefit intensive culture blood;Cortex Moutan has effect of clearing away heat and cooling blood, promoting blood circulation to remove blood stasis;Flos Rosae Rugosae has effect of promoting QI circulation for relieving depression, promoting blood flow to regulate menstruation;Tabanus have removing blood stasis stimulate the menstrual flow, effect of removing blood stasis eliminating mass;Ludwigia octovalvis (Jacq.) Raven has heat-clearing and toxic substances removing, effect of diuresis hemostasis;Herba Taraxaci has effect of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, inducing diuresis for treating stranguria syndrome;Radix rosae multiflorae has heat-clearing and toxic substances removing, expelling wind and removing dampness, promoting blood flow to regulate menstruation, controlling nocturnal emission with astringent drugs reducing urination, the effect of a fishbone or other bone caught in the throat that disappears.Drug component in the present composition, through dialectical compatibility, complements each other using, and has synergism, and long memorial liver spleen, blood circulation promoting and blood stasis dispelling, promoting QI circulation for relieving depression, effect of hard masses softening and resolving, reach the purpose for the treatment of both the principal and secondary aspects of a disease to hysteromyoma altogether.
The component of the present composition all uses natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, low cost.It follows the prescriptions principle of the traditional Chinese medical science, and various component drug use the use that is decocted in water for oral dose.Verifying by clinic application, it is evident in efficacy, reliable effect, mild in medicine property and, toxic and side effects does not occurs, total effective rate 90.4%, cure rate reaches 57.7%.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1
A kind of Chinese medicine composition treating hysteromyoma, its raw material of Chinese medicine and weight proportion be: Radix Codonopsis 20g, Radix Paeoniae Rubra 15g, Rhizoma Cyperi 10g, Eupolyphaga Seu Steleophaga 15g, Herba Cleomis 15g, Spica Prunellae 15g, Olibanum 10g, Concha Arcae 15g, Ramulus Cinnamomi 15g, Poria 15g, Sargassum 10g, sting fossilia dentis mastodi 15g, Fructus Rubi 15g, Radix Angelicae Sinensis 15g, Ramulus Euonymi 10g, Concha Meretricis seu Cyclinae 15g, Fructus Forsythiae 15g, Colla cornus cervi 10g, Cortex Moutan 15g, Flos Rosae Rugosae 15g, Tabanus 10g, Ludwigia octovalvis (Jacq.) Raven 15g, Herba Taraxaci 15g, Radix rosae multiflorae 15g.
Embodiment 2
A kind of Chinese medicine composition treating hysteromyoma, its raw material of Chinese medicine and weight proportion be: Radix Codonopsis 30g, Radix Paeoniae Rubra 10g, Rhizoma Cyperi 15g, Eupolyphaga Seu Steleophaga 10g, Herba Cleomis 20g, Spica Prunellae 10g, Olibanum 15g, Concha Arcae 10g, Ramulus Cinnamomi 20g, Poria 10g, Sargassum 15g, sting fossilia dentis mastodi 10g, Fructus Rubi 20g, Radix Angelicae Sinensis 10g, Ramulus Euonymi 15g, Concha Meretricis seu Cyclinae 10g, Fructus Forsythiae 20g, Colla cornus cervi 5g, Cortex Moutan 20g, Flos Rosae Rugosae 10g, Tabanus 15g, Ludwigia octovalvis (Jacq.) Raven 10g, Herba Taraxaci 20g, Radix rosae multiflorae 10g.
Embodiment 3
A kind of Chinese medicine composition treating hysteromyoma, its raw material of Chinese medicine and weight proportion be: Radix Codonopsis 10g, Radix Paeoniae Rubra 20g, Rhizoma Cyperi 5g, Eupolyphaga Seu Steleophaga 20g, Herba Cleomis 10g, Spica Prunellae 20g, Olibanum 5g, Concha Arcae 20g, Ramulus Cinnamomi 10g, Poria 20g, Sargassum 5g, sting fossilia dentis mastodi 20g, Fructus Rubi 10g, Radix Angelicae Sinensis 20g, Ramulus Euonymi 5g, Concha Meretricis seu Cyclinae 20g, Fructus Forsythiae 10g, Colla cornus cervi 15g, Cortex Moutan 10g, Flos Rosae Rugosae 20g, Tabanus 5g, Ludwigia octovalvis (Jacq.) Raven 20g, Herba Taraxaci 10g, Radix rosae multiflorae 20g.
Embodiment 4
A kind of Chinese medicine composition treating hysteromyoma, its raw material of Chinese medicine and weight proportion be: Radix Codonopsis 23g, Radix Paeoniae Rubra 12g, Rhizoma Cyperi 13g, Eupolyphaga Seu Steleophaga 12g, Herba Cleomis 17g, Spica Prunellae 12g, Olibanum 13g, Concha Arcae 12g, Ramulus Cinnamomi 17g, Poria 12g, Sargassum 13g, sting fossilia dentis mastodi 12g, Fructus Rubi 17g, Radix Angelicae Sinensis 12g, Ramulus Euonymi 13g, Concha Meretricis seu Cyclinae 12g, Fructus Forsythiae 17g, Colla cornus cervi 7g, Cortex Moutan 17g, Flos Rosae Rugosae 12g, Tabanus 13g, Ludwigia octovalvis (Jacq.) Raven 12g, Herba Taraxaci 18g, Radix rosae multiflorae 12g.
Embodiment 5
A kind of Chinese medicine composition treating hysteromyoma, its raw material of Chinese medicine and weight proportion be: Radix Codonopsis 17g, Radix Paeoniae Rubra 18g, Rhizoma Cyperi 7g, Eupolyphaga Seu Steleophaga 18g, Herba Cleomis 12g, Spica Prunellae 18g, Olibanum 7g, Concha Arcae 18g, Ramulus Cinnamomi 12g, Poria 18g, Sargassum 7g, sting fossilia dentis mastodi 18g, Fructus Rubi 12g, Radix Angelicae Sinensis 18g, Ramulus Euonymi 7g, Concha Meretricis seu Cyclinae 18g, Fructus Forsythiae 12g, Colla cornus cervi 13g, Cortex Moutan 12g, Flos Rosae Rugosae 18g, Tabanus 7g, Ludwigia octovalvis (Jacq.) Raven 18g, Herba Taraxaci 12g, Radix rosae multiflorae 18g.
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament.Concrete grammar is as follows: put in container by the raw material of Chinese medicine of prescription, adds cold water and covers powder, soak 15~20 minutes, added water no powder about 6 centimetres, carries out decocting for the first time, at a simmer before use intense fire to decoct, with slow fire boiling 20~30 minutes after boiling;Second time decocts, and added water no powder about 6 centimetres, decocts 15~20 minutes after water boiling.Twice decoction is removed slag extracting juice, merges.
The present invention, with a kind of Chinese medicine composition treating hysteromyoma given by embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: Chinese medicine composition of the present invention is applied to clinical observation case female 52 example, age 30~50 years old.The shortest person of the course of disease 5 months, elder reach 5 years, average 1 year.
Two, diagnostic criteria:
1, menorrhagia, menostaxis or irregular bleeding, lower abdomen may occur in which that lump, minority have pain and pressure symptom, or companion's basin blood;
2, uterus increases, and matter is hard;
3, detection uterine cavity increases or deformation;
4, examine and when scraping, in uterine cavity, touch crowning;
5, B ultrasonic or uteroscopy can assist to check..
Three, usage and dosage: during clinical practice, one day potion, decocting twice extracting juice about 300ml, point early, late twice warm is taken, and within seven days, is a course for the treatment of.
Four, criterion of therapeutical effect:
1, cure: muscular tumor disappears, clinical symptom disappearance;
2, take a turn for the better: clinical symptom relief or disappearance, muscular tumor reduces more than 1/2;
3, do not heal: symptom is without changing, and muscular tumor has no substantially disappearance.
Five, therapeutic effect: in this clinical observation case, take medicine 4-12 the course for the treatment of, cure 30 examples, take a turn for the better 17 examples, the most 5 examples.Toxic and side effects is there is not during treatment.
Six, model case:
Case 1: Zhao, female, 38 years old.The readme always dripping urine endlessly of menstruation at no distant date time medical, menstrual cycle shortens, and touches hypogastric region with hands, and having obvious lump, ultrasound diagnosis result is hysteromyoma.After 4 courses for the treatment of of medicament taking prepared by the Chinese medicine composition of the present invention, conscious menstruation and leukorrhagia situation are clearly better;Continue to take 5 courses for the treatment of, each transference cure, cure.
Case 2: Cui, female, 47 years old.Time medical readme from the beginning of time occur that menstrual blood volume increases without obvious inducement, color is red, without clot, companion's dysmenorrhea.Look into B ultrasonic prompting hysteromyoma at local hospital, give the medicines such as tamoxifen to suppress tumor to increase, DeGrain.Taking 7 courses for the treatment of of medicament prepared by the Chinese medicine composition of the present invention, hysteromyoma stops growing, and through bimestrial treatment, tumor is obviously reduced;Continue after taking 4 courses for the treatment of, tumor disappearance, follow up a case by regular visits to half a year, without recurrence.
Claims (2)
- null1. the Chinese medicine composition treating hysteromyoma,It is characterized in that: its raw material of Chinese medicine and weight be: Radix Codonopsis 10-30 part,Radix Paeoniae Rubra 10-20 part,Rhizoma Cyperi 5-15 part,Eupolyphaga Seu Steleophaga 10-20 part,Herba Cleomis 10-20 part,Spica Prunellae 10-20 part,Olibanum 5-15 part,Concha Arcae 10-20 part,Ramulus Cinnamomi 10-20 part,Poria 10-20 part,Sargassum 5-15 part,Thorn fossilia dentis mastodi 10-20 part,Fructus Rubi 10-20 part,Radix Angelicae Sinensis 10-20 part,Ramulus Euonymi 5-15 part,Concha Meretricis seu Cyclinae 10-20 part,Fructus Forsythiae 10-20 part,Colla cornus cervi 5-15 part,Cortex Moutan 10-20 part,Flos Rosae Rugosae 10-20 part,Tabanus 5-15 part,Ludwigia octovalvis (Jacq.) Raven 10-20 part,Herba Taraxaci 10-20 part,Radix rosae multiflorae 10-20 part.
- A kind of Chinese medicine composition treating hysteromyoma the most according to claim 1, it is characterized in that: its raw material of Chinese medicine and weight be: Radix Codonopsis 20 parts, Radix Paeoniae Rubra 15 parts, Rhizoma Cyperi 10 parts, Eupolyphaga Seu Steleophaga 15 parts, Herba Cleomis 15 parts, Spica Prunellae 15 parts, Olibanum 10 parts, Concha Arcae 15 parts, Ramulus Cinnamomi 15 parts, 15 parts of Poria, Sargassum 10 parts, thorn fossilia dentis mastodi 15 parts, Fructus Rubi 15 parts, Radix Angelicae Sinensis 15 parts, Ramulus Euonymi 10 parts, Concha Meretricis seu Cyclinae 15 parts, Fructus Forsythiae 15 parts, Colla cornus cervi 10 parts, Cortex Moutan 15 parts, Flos Rosae Rugosae 15 parts, Tabanus 10 parts, Ludwigia octovalvis (Jacq.) Raven 15 parts, Herba Taraxaci 15 parts, Radix rosae multiflorae 15 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610254199.XA CN105770294A (en) | 2016-04-23 | 2016-04-23 | Traditional Chinese medicine composition for treating hysteromyoma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610254199.XA CN105770294A (en) | 2016-04-23 | 2016-04-23 | Traditional Chinese medicine composition for treating hysteromyoma |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105770294A true CN105770294A (en) | 2016-07-20 |
Family
ID=56398205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610254199.XA Pending CN105770294A (en) | 2016-04-23 | 2016-04-23 | Traditional Chinese medicine composition for treating hysteromyoma |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105770294A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107812162A (en) * | 2017-12-24 | 2018-03-20 | 南宁多灵生物科技有限公司 | A kind of drug regimen for treating fibroid |
CN115177686A (en) * | 2022-08-18 | 2022-10-14 | 邵伟超 | Medicine for treating submucosal hysteromyoma and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104324330A (en) * | 2014-11-20 | 2015-02-04 | 解淑琼 | Traditional Chinese medicine composition for treating blood stasis accumulation type hysteromyoma and preparation method of the traditional Chinese medicine composition |
-
2016
- 2016-04-23 CN CN201610254199.XA patent/CN105770294A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104324330A (en) * | 2014-11-20 | 2015-02-04 | 解淑琼 | Traditional Chinese medicine composition for treating blood stasis accumulation type hysteromyoma and preparation method of the traditional Chinese medicine composition |
Non-Patent Citations (2)
Title |
---|
刘凤新: "自拟盆炎活血汤治疗慢性盆腔炎445例疗效观察", 《吉林医学》 * |
王华丽: "中西医结合治疗子宫肌瘤109例疗效分析", 《光明中医》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107812162A (en) * | 2017-12-24 | 2018-03-20 | 南宁多灵生物科技有限公司 | A kind of drug regimen for treating fibroid |
CN115177686A (en) * | 2022-08-18 | 2022-10-14 | 邵伟超 | Medicine for treating submucosal hysteromyoma and preparation method thereof |
CN115177686B (en) * | 2022-08-18 | 2024-04-02 | 邵伟超 | Medicine for treating submucosal hysteromyoma and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102988672B (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
CN102512630A (en) | Traditional Chinese medicine composition for treating gallbladder calculus | |
CN103784887A (en) | Traditional Chinese medicinal composition for treating kidney deficiency lumbago | |
CN102895460B (en) | Traditional Chinese medicine composition for fracture and soft tissue injury | |
CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
CN104173856A (en) | Traditional Chinese medicine composition for treating morbid leukorrhea | |
CN103565969A (en) | Traditional Chinese medicine composition for treating soft tissue injury and fracture | |
CN105770294A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
CN103041301B (en) | Traditional Chinese medicine composition for treating icterohepatitis | |
CN103127458A (en) | Drug for treating osteoarticular myalgia | |
CN105749167A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
CN105770400A (en) | Traditional Chinese medicine composition for treating puerperal infection | |
CN103191305A (en) | Traditional Chinese medicine composition for treating hyperosteogeny | |
CN105687909A (en) | Traditional Chinese medicine composition for treating dysuria | |
CN105853782A (en) | Traditional Chinese medicinal composition for treating uterine prolapsed | |
CN105748754A (en) | Traditional Chinese medicine composition for treating uterine prolapse | |
CN105770478A (en) | Traditional Chinese medicine composition for treating bladder cancer | |
CN105749077A (en) | Traditional Chinese medicine composition for treating female infertility | |
CN105749166A (en) | Traditional Chinese medicine composition for treating uterine fibroid | |
CN105687872A (en) | Traditional Chinese medicinal composition for treating urethritis | |
CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
CN103751715A (en) | Traditional Chinese medicine composition for treating pelvic inflammation | |
CN104800632A (en) | Traditional Chinese medicine composition for treating kidney stone | |
CN103720986A (en) | Traditional Chinese medicine composition for treating leukorrhea | |
CN105770561A (en) | Traditional Chinese medicine composition for treating ovarian cyst |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160720 |